ArticleCureus2026
Purple Urine Bag Syndrome as a Visual Trigger for Overtreatment: A Case Report and Aggregated Literature Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purple urine bag syndrome (PUBS) is an uncommon yet visually striking clinical phenomenon characterized by purple discoloration of urinary drainage systems in patients with indwelling urinary devices. Although alarming, it most often occurs in elderly or chronically ill patients with multiple risk factors for urinary bacterial colonization and does not typically represent a pathologic entity. PUBS is often accompanied by abnormal urine studies, which may prompt antimicrobial treatment even in the absence of clear clinical infection. We report a hospice patient with an indwelling urinary catheter who developed PUBS without localized urinary symptoms or systemic signs of infection. The patient remained clinically stable, and the treating hospice team did not initiate laboratory evaluation or antibiotic therapy. However, the long-term care facility subsequently administered intravenous ertapenem in response to urine culture results obtained during the episode. The purple discoloration resolved without clinical deterioration. This case illustrates how PUBS may trigger treatment escalation based on laboratory findings rather than clinical presentation, particularly in vulnerable patients, and was the impetus for a focused examination of management principles described in published reports. Careful interpretation of PUBS within the context of patient symptoms and goals of care may help avoid unnecessary interventions and support more judicious antimicrobial use and antibiotic stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.